Single Dose of the Antivascular Agent, ZD6126 (N-Acetylcolchinol-O-Phosphate), Reduces Perfusion for at Least 96 Hours in the GH3 Prolactinoma Rat Tumor Model

Por McIntyre, Dominick J O, Robinson, Simon P, Howe, Franklyn A, Griffiths, John R, Ryan, Anderson J, Blakey, David C, Peers, Ian S, Waterton, John C
Publicado em 2004

Challenges and key considerations of the enhanced permeability and retention (EPR) effect for nanomedicine drug delivery in oncology

Por Prabhakar, Uma, Maeda, Hiroshi, Jain, Rakesh K., Sevick-Muraca, Eva M., Zamboni, William, Farokhzad, Omid C., Barry, Simon T., Gabizon, Alberto, Grodzinski, Piotr, Blakey, David C.
Publicado em 2013

Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer

Por Voutila, Jon, Reebye, Vikash, Roberts, Thomas C., Protopapa, Pantelitsa, Andrikakou, Pinelopi, Blakey, David C., Habib, Robert, Huber, Hans, Saetrom, Pal, Rossi, John J., Habib, Nagy A.
Publicado no Mol Ther (2017)

Acute Tumor Response to ZD6126 Assessed by Intrinsic Susceptibility Magnetic Resonance Imaging

Por Robinson, Simon P, Kalber, Tammy L, Howe, Franklyn A, McIntyre, Dominick J O, Griffiths, John R, Blakey, David C, Whittaker, Lynsey, Ryan, Anderson J, Waterton, John C
Publicado em 2005

Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer

Por Reebye, Vikash, Huang, Kai-Wen, Lin, Vivian, Jarvis, Sheba, Cutilas, Pedro, Dorman, Stephanie, Ciriello, Simona, Andrikakou, Pinelopi, Voutila, Jon, Saetrom, Pal, Mintz, Paul J, Reccia, Isabella, Rossi, John J, Huber, Hans, Habib, Robert, Kostomitsopoulos, Nikos, Blakey, David, Habib, Nagy
Publicado no Oncogene (2018)

A screening tool to prioritize public health risk associated with accidental or deliberate release of chemicals into the atmosphere

Por Blakey, David H, Lafontaine, Marc, Lavigne, Jocelyn, Sokolowski, Danny, Philippe, Jean-Marc, Sapori, Jean-Marc, Biederbick, Walter, Horre, Regine, Marzi, Willi B, Kondo, Hisayoshi, Kuroki, Yumiko, Namera, Akira, Okumura, Tetsu, Yamamoto, Miyako, Yashiki, Mikio, Blain, Peter G, Russell, David R, Cibulsky, Susan M, Jett, David A
Publicado em 2013

Meeting Report: Validation of Toxicogenomics-Based Test Systems: ECVAM–ICCVAM/NICEATM Considerations for Regulatory Use

Por Corvi, Raffaella, Ahr, Hans-Jürgen, Albertini, Silvio, Blakey, David H., Clerici, Libero, Coecke, Sandra, Douglas, George R., Gribaldo, Laura, Groten, John P., Haase, Bernd, Hamernik, Karen, Hartung, Thomas, Inoue, Tohru, Indans, Ian, Maurici, Daniela, Orphanides, George, Rembges, Diana, Sansone, Susanna-Assunta, Snape, Jason R., Toda, Eisaku, Tong, Weida, van Delft, Joost H., Weis, Brenda, Schechtman, Leonard M.
Publicado em 2006

AZD9150, a Next-Generation Antisense Oligonucleotide Inhibitor of STAT3 with Early Evidence of Clinical Activity in Lymphoma and Lung Cancer

Por Hong, David, Kurzrock, Razelle, Kim, Youngsoo, Woessner, Richard, Younes, Anas, Nemunaitis, John, Fowler, Nathan, Zhou, Tianyuan, Schmidt, Joanna, Jo, Minji, Lee, Samantha J., Yamashita, Mason, Hughes, Steven G., Fayad, Luis, Piha-Paul, Sarina, Nadella, Murali VP, Mohseni, Morvarid, Lawson, Deborah, Reimer, Corinne, Blakey, David C., Xiao, Xiaokun, Hsu, Jeff, Revenko, Alexey, Monia, Brett P., MacLeod, A. Robert
Publicado no Sci Transl Med (2015)

International study of factors affecting human chromosome translocations

Por Sigurdson, Alice J., Ha, Mina, Hauptmann, Michael, Bhatti, Parveen, Sram, Radim J., Beskid, Olena, Tawn, E. Janet, Whitehouse, Caroline A., Lindholm, Carita, Nakano, Mimako, Kodama, Yoshiaki, Nakamura, Nori, Vorobtsova, Irena, Oestreicher, Ursula, Stephan, Günther, Yong, Lee C., Bauchinger, Manfred, Schmid, Ernst, Chung, Hai Won, Darroudi, Firouz, Roy, Laurence, Voisin, Phillipe, Barquinero, Joan F., Livingston, Gordon, Blakey, David, Hayata, Isamu, Zhang, Wei, Wang, Chunyan, Bennett, L. Michelle, Littlefield, L. Gayle, Edwards, Alan A., Kleinerman, Ruth A., Tucker, James D.
Publicado em 2008